Market Overview - The biopharmaceutical sector increased by 0.27% on August 19, with Olin Bio leading the gains [1] - The Shanghai Composite Index closed at 3727.29, down 0.02%, while the Shenzhen Component Index closed at 11821.63, down 0.12% [1] Top Performers - Olin Bio (688319) closed at 31.21, up 12.71% with a trading volume of 275,600 shares and a transaction value of 831 million [1] - Nossland (430047) closed at 28.44, up 11.53% with a trading volume of 211,700 shares and a transaction value of 622 million [1] - Ganli Pharmaceutical (603087) closed at 68.03, up 6.95% with a trading volume of 406,100 shares and a transaction value of 2.793 billion [1] Underperformers - Junshi Biosciences (688180) closed at 45.32, down 3.70% with a trading volume of 210,400 shares and a transaction value of 977 million [2] - ZhiXiangQuanTai (688443) closed at 33.05, down 3.42% with a trading volume of 77,200 shares and a transaction value of 260 million [2] - SanShengGuoJian (688336) closed at 54.10, down 2.50% with a trading volume of 85,900 shares and a transaction value of 477 million [2] Capital Flow - The biopharmaceutical sector saw a net inflow of 250 million from institutional investors, while retail investors experienced a net outflow of 379 million [2][3] - Major stocks like Shenzhou Cell (688520) had a net inflow of 1.39 billion from institutional investors, but a net outflow of 1.08 billion from retail investors [3]

Core Viewpoint - The legal opinion letter confirms the legality and validity of the procedures, qualifications of attendees, and voting results of the 2025 first extraordinary general meeting of Shandong Weiming Bio-Pharmaceutical Co., Ltd. [1][11] Group 1: Meeting Procedures - The meeting was proposed and convened by the board of directors, with the notice published on July 31, 2025, in designated media and on the Shenzhen Stock Exchange website [2][3] - The meeting combined on-site voting and online voting, held on August 15, 2025, at a specified location in Zibo City, Shandong Province [2][3] Group 2: Attendee Qualifications - Attendees included all registered shareholders of the Shenzhen branch, with the option to appoint proxies [5] - A total of 323 participants attended the meeting, representing 143,261,055 shares, which is 21.7149% of the total voting shares [5] Group 3: Voting Procedures and Results - The voting process adhered to legal and regulatory requirements, with results announced immediately after voting [6][9] - The voting results showed that the proposals received overwhelming support, with significant majorities in favor, including 97.8610% for one proposal and 97.4201% for another [6][8][9]

Meeting Details - The meeting was held on August 15, 2025, at 2:30 PM, with online voting available from 9:15 AM to 3:00 PM on the same day [1] - A total of 323 shareholders participated, representing 143,261,055 shares, which is 21.7149% of the total voting shares [1] Shareholder Participation - Among the participants, 9 shareholders voted in person, representing 135,985,362 shares (20.6121% of total voting shares), while 314 shareholders voted online, representing 7,275,693 shares (1.1028% of total voting shares) [2][3] Proposal Voting Results - Proposal 1: Amendment to the Articles of Association - Votes in favor: 140,196,722 shares (97.8610%) - Votes against: 3,022,233 shares (2.1096%) - Abstentions: 0.0294% [2] - Proposal 2: Amendment to the Rules of Procedure for Shareholders' Meetings - Votes in favor: 139,565,062 shares (97.4201%) - Votes against: 3,653,893 shares (2.5505%) - Abstentions: 0.0294% [3][4] - Proposal 3: Amendment to the Rules of Procedure for Board Meetings - Votes in favor: 139,565,262 shares (97.4202%) - Votes against: 3,653,693 shares (2.5504%) - Abstentions: 0.0294% [4] - Proposal 4: Amendment to the Independent Director Work Rules - Votes in favor: 139,565,762 shares (97.4206%) - Votes against: 3,653,693 shares (2.5504%) - Abstentions: 0.0290% [5] - Proposal 5: Establishment of the Senior Management Compensation System - Votes in favor: 140,125,922 shares (97.8116%) - Votes against: 3,065,033 shares (2.1395%) - Abstentions: 0.0489% [5] - Proposal 6: Sixth Board Compensation Plan - Votes in favor: 140,122,122 shares (97.8089%) - Votes against: 3,069,333 shares (2.1425%) - Abstentions: 0.0486% [6] Legal Opinion - The legal opinion confirmed that the qualifications of the attendees and the voting procedures complied with legal and regulatory requirements, making the voting results valid [6]

证券代码：002581 证券简称：ST未名 公告编号：2025-061 山东未名生物医药股份有限公司 2025 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，不存在虚 假记载、误导性陈述或重大遗漏。 特别提示 1. 本次股东会未出现否决议案的情形； ①通过深圳证券交易所交易系统进行投票的时间：2025 年 8 月 15 日上午 9:15-9:25，9:30-11:30，下午 1:00-3:00； ②通过互联网投票系统进行网络投票的时间：2025 年 8 月 15 日 9:15-15:00。 2. 现场会议地点：山东省淄博市张店区马尚街道办事处心环东路与荣二路 交汇处齐美大厦 27 层 2. 本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开情况 1. 会议召开时间： （1）现场会议召开时间：2025 年 8 月 15 日下午 2:30 （2）网络投票时间： 3. 会议召开方式：现场投票与网络投票相结合 4. 会议召集人：公司董事会 5. 会议主持人：董事长岳家霖 6. 本次会议的召集、召开和表决程序符合《公司法》等法律、法规、规范 性文件及《公司章程》的有关规定 ...

浙江天册（深圳）律师事务所 关于 山东未名生物医药股份有限公司 2025 年第一次临时股东会的 法律意见书 中国广东省深圳市南山区科发路 222 号康泰创新广场 34 层 518057 电话：0755-26907494 传真：0755-26906383 http://www.tclawfirm.com 法律意见书 浙江天册（深圳）律师事务所 关于山东未名生物医药股份有限公司 2025 年第一次临时股东会的 法律意见书 致：山东未名生物医药股份有限公司 浙江天册（深圳）律师事务所（以下简称本所）接受山东未名生物医药股份有 限公司（以下简称公司）的委托，指派本所律师参加公司 2025 年第一次临时股东 会（以下简称本次股东会），并根据《中华人民共和国证券法》（以下简称《证券 法》）、《中华人民共和国公司法》（以下简称《公司法》）、《上市公司股东会 规则》（以下简称《股东会规则》）以及《山东未名生物医药股份有限公司章程》 （以下简称《公司章程》）等法律、法规和其他有关规范性文件的要求出具本法律 意见书。 在本法律意见书中，本所律师仅对本次股东会召集、召开程序、出席人员的资 格、召集人的资格、表决程序及表决结果的合法 ...

Core Viewpoint - The adjustment of the CSI 1000 Index sample stocks is effective after the market closes on August 8, 2025, with three stocks being added and three ST stocks being removed [1][3][4]. Group 1: Index Adjustment Details - Three stocks, Wanhe Electric, Tefa Service, and Electric Wind Power, have been added to the CSI 1000 Index, while three ST stocks, ST Weiming, ST Emergency, and ST Nuotai, have been removed [4]. - The newly added stocks have shown strong performance recently, with Wanhe Electric rising by 7.44% on August 8 and a cumulative increase of 17.56% from August 6 to August 8; Electric Wind Power increased by 2.61% on August 8 and 19.23% cumulatively during the same period [4]. - Tefa Service, however, experienced a decline of 2.10% on August 8 and a slight decrease of 1.15% cumulatively from August 6 to August 8 [4]. Group 2: Index Performance - The CSI 1000 Index has performed well overall, with a cumulative increase of 14.78% year-to-date, outperforming the Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index [7]. - Since the third quarter of 2025, the CSI 1000 Index has seen a cumulative increase of 7.58%, indicating an acceleration in growth compared to the first and second quarters [7]. - On August 7, 2025, the index reached a high of 6876.50 points, marking the highest level since April 21, 2023 [7]. Group 3: Stock Performance - Over 80% of the 1000 sample stocks in the CSI 1000 Index have risen since the third quarter of 2025, with nearly 20 stocks achieving a cumulative increase of over 50% [8]. - Year-to-date, approximately 746 stocks have increased, representing about three-quarters of the sample, with 120 stocks showing gains exceeding 50% [8]. - Notable stocks with over 100% cumulative gains this year include Changcheng Military Industry, Yipinhong, and others [8].

Group 1 - The core point of the article is the adjustment of the CSI 1000 Index samples, which will take effect after the market closes on August 8, 2025 [1] Group 2 - The companies added to the CSI 1000 Index include Wanhe Electric, TeFa Service, and Electric Wind Power [1] - The companies removed from the CSI 1000 Index are ST Weiming, ST Emergency, and ST Nuotai [1]

中证指数有限公司公告称，决定调整中证1000指数样本，于2025年8月8日收市后生效，调入万和电气、 特发服务、电气风电，调出ST未名、ST应急、ST诺泰。 ...

8月5日，据中证指数有限公司网站，根据指数临时调样规则及编制方案，中证指数有限公司决定调整中 证1000指数样本，于2025年8月8日收市后生效。调入万和电气、特发服务、电气风电，调出ST未名、 ST应急、ST诺泰。 ...

证券代码：002581 证券简称：ST未名 公告编号：2025-060 山东未名生物医药股份有限公司 关于完成子公司相关变更的进展公告 | 变更事项 | 公司治理 | 法定代表人 | 董事长 | 董事 | 总经理 | | --- | --- | --- | --- | --- | --- | | 变更前 | 执行董事制度 | 岳家霖 | -- | 岳家霖 | 徐隽雄 | | 变更后 | 董事会制度 | 陈星 | 徐隽雄 | 徐隽雄、周 | 陈星 | | | | | | 婷、陈星 | | 根据上述变更情况，厦门未名已将其《公司章程》进行相应的修订后并完成 工商备案。 二、山东衍渡变更情况 根据淄博市张店区行政审批服务局最终核准登记信息，山东衍渡工商变更后 具体情况如下： | 变更事项 | 经营范围 | | --- | --- | | 变更前 | 一般项目：技术服务、技术开发、技术咨询、技术交 | | | 流、技术转让、技术推广；生物化工产品技术研发。 | | | （除依法须经批准的项目外，凭营业执照依法自主开展 | | | 经营活动） | | 变更后 | 一般项目：技术服务、技术开发、技术咨询、技术交 | | ...